Technology transfer

We advise you on efficient and streamlined technology transfers and successful development, manufacturing and implementation of the project. We also support you through to clinical trials to ensure successful commercialisation.

For each stage from lab scale to Pilot to Commercial, scale, our team ensure process optimisation for higher yields while also focusing on batch-to-batch consistency based output, whether the tech transfer is within the organisation or outsourced/out-licensed at any stage. For out-licencing, we also support you by conducting a thorough due diligence that allows you to seal the deal with zero stress.

Our deliverables include

  • End-to-end tech transfers for polysaccharide, recombinant and toxoid based vaccine development and commercial manufacturing
  • End-to-end tech transfer support for biosimilar development and manufacturing
  • Supplies of finished products, unformulated, formulated (ready-to-fill bulks) for various vaccine antigens and biosimilar products

Our clients include pharma and biotech companies as well as lifesciences and financial investors.

Strategic Partners

We help local companies and organisations in the developing world secure long-term supply contracts of quality, affordable vaccines and biosimilars through project localisation initiatives and partnerships with established manufacturers of biotech/biological products.

Strategic Partners

We help local companies and organisations in the developing world secure long-term supply contracts of quality, affordable vaccines and biosimilars through project localisation initiatives and partnerships with established manufacturers of biotech/biological products.

Can we help?


Read the stories behind the science

We helped set up the first indigenous vaccine manufacturing facility in Central America
We enabled the first successful development of a contemporary recombinant vaccine in Turkey

Health inequities are differences in health status and mortality rates across population groups that are systemic, avoidable, unfair and unjust.

Margaret Whitehead

Close Menu

Techinvention featured in Silicon Healthcare’s top 10 promising biotech companies 2019.

Read the article